Controlling severe atopic dermatitis dynamics

Area of Science:

• Dermatology and Mathematical Biology
• Computational and Systems Biology

Background:

• Atopic dermatitis (AD) is a chronic inflammatory skin disease with severe forms proving refractory to standard treatments.
• Managing severe AD involves controlling acute inflammation and sustaining long-term remission, posing a significant clinical challenge.

Purpose of the Study:

• To establish a mathematical framework for analyzing the dynamics of severe atopic dermatitis treatment.
• To determine the minimal drug doses required for effective control in distinct therapeutic phases.

Main Methods:

• Development of a mathematical model for a two-phase clinical strategy: "Get Control" (GC) and "Keep Control" (KC).
• Analysis of scaling laws linking drug dosage to disease determinants like barrier permeability and immune clearance capacity.

Main Results:

• Identified scaling laws that quantitatively define the relationship between drug dose and severe AD characteristics.
• Delineated specific antibiotic dosages for the GC phase to resolve inflammation and emollient levels for the KC phase to maintain remission.

Conclusions:

• The framework provides a quantitative, phase-based approach to severe AD treatment, moving beyond heuristic methods.
• Uncovered principles enable personalized, optimally dosed strategies for refractory atopic dermatitis, aligning treatment with disease dynamics.